<!--
Filename: 	2019-04-08_14M.md
Project: 	/Users/shume/Developer/physician/Neurol/TNI
Author: 	shumez <https://github.com/shumez>
Created: 	2019-04-09 14:58:1
Modified: 	2019-05-31 16:12:44
-----
Copyright (c) 2019 shumez
-->

# [Teaching NeuroImages: Lacunar stroke and polyarteritis nodosa ~Consider ADA2 deficiency (DADA2)~][2019LucatoLT_AlvesCAPF_GonçalvesTdS]

## Summary

* 14yo M
* PMHx
    * –7y livedo reticularis
* Tentative Dx
    * cutaneous polyarteritis nodosa
        * acute impaired taste & tactile sensation on tongue
* HPI
    * – 1y Lt partial oculomotor palsy (lacunar midbrain stroke)
* Ex
    * DWI
        * multifocal VB ischemia 
    * exome sequencing
        * **ADA2** 
* Rx
    * adalimumab (anti-TNF)

## Terminology

## Original

> A 14-year-old boy with a 7-year history of livedo reticularis ([figure 1](#fig1)) and initial diagnosis of **cutaneous polyarteritis nodosa** presented with acute impaired taste and tactile sensation on the tongue. One year prior, he showed left partial oculomotor palsy due to a lacunar midbrain stroke ([figure 2A](#fig2)). New imaging ([figure 2, B and C](#fig2)) revealed multifocal vertebrobasilar ischemia. Exome sequencing demonstrated compound heterozygosity in **ADA2** (an intronic and a G47R^[1][2016GattornoM_PencoF_CaorsiR]^ mutation), confirming adenosine deaminase 2 deficiency, an early-onset autoinflammatory disease characterized by features of polyarteritis nodosa and stroke.^[2][2017GattornoM_PencoF_CaorsiR]^ The treatment was changed to adalimumab, whereas anti-tumor necrosis factor drugs are considered as first-line therapy.^[2][2017GattornoM_PencoF_CaorsiR],[3][2018AksentijevichI_MeytsI]^

###### Figure 1

> Cutaneous feature  
> Livedo reticularis.

[![Fig.1][fig_01]][fig_01]


###### Figure 2

> MRI findings  
> Very small acute ischemic foci, showing diffusion-weighted imaging hyperintensity.  
> (A) First stroke involving left paramedian caudal midbrain.  
> (B, C) Second stroke involving right midbrain lateral tegmentum (B) and hypothalamus left wall (C).

[![Fig.2][fig_02]][fig_02]


## 
[2019LucatoLT_AlvesCAPF_GonçalvesTdS]: https://n.neurology.org/content/92/15/e1801

<!-- fig -->
[fig_01]: https://n.neurology.org/content/neurology/92/15/e1801/F1.medium.gif "Figure 1. Cutaneous feature"
[fig_02]: https://n.neurology.org/content/neurology/92/15/e1801/F2.medium.gif "Figure 2. MRI findings"

<!-- ref -->
[2016GattornoM_PencoF_CaorsiR]: https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-016-0111-7 "Caorsi, R., Penco, F., Schena, F. and Gattorno, M., 2016. Monogenic polyarteritis: the lesson of ADA2 deficiency. Pediatric Rheumatology, 14(1), p.51."
[2017GattornoM_PencoF_CaorsiR]: https://ard.bmj.com/content/76/10/1648?utm_source=trendmd&utm_medium=cpc&utm_campaign=alljjs&utm_content=americas&utm_term=1-B "Caorsi, R., Penco, F., Grossi, A., Insalaco, A., Omenetti, A., Alessio, M., Conti, G., Marchetti, F., Picco, P., Tommasini, A. and Martino, S., 2017. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Annals of the rheumatic diseases, 76(10), pp.1648-1656."
[2018AksentijevichI_MeytsI]: https://link.springer.com/article/10.1007/s10875-018-0525-8 "Meyts, I. and Aksentijevich, I., 2018. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. Journal of clinical immunology, 38(5), pp.569-578."